The article reports on the decision of NMT Medical to close its patent foramen ovale (PFO)/migraine trial, MIST II. The trial was evaluating the safety and efficacy of BioStar implant for the treatment and prevention of migraine headaches in PFO patients. It was designed as a double-blindend...
The evaluation of response to immunotherapy in metastatic renal cell carcinoma: open challenges in the clinical practice http://www.ncbi.nlm.nih.gov/pubmed/31480348 Int J Mol Sci, 20 (2019), p. 4263 doi:10.3390/ijms20174263 Google Scholar 15. A. Rodriguez-Vida, M. Strijbos, T. Hutson Pr...
The emergence of JN.1 highlights the ongoing pandemic challenges, emphasizing the critical need for vaccine advancement [14,15]. PHH-1V, a bivalent protein-based adjuvanted vaccine, has emerged as a promising booster [16]. Phase IIb trials demonstrated its efficacy in generating neutralizing ...